Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer

PURPOSE: Host immunity influences the impact of cancer therapy but the effect of immune status in radioiodine (RAI)-treated differentiated thyroid cancer (DTC) remains obscure. Here we investigated indoleamine 2,3-dioxygenase (IDO) activity as a biomarker of response to RAI in patients with distant...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Liang, Duan, Rui, Jia, Qiong, Wu, Wenyu, Zhou, Jianming, Li, Shaohua, Zhang, Hao, Xue, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339611/
https://www.ncbi.nlm.nih.gov/pubmed/35924153
http://dx.doi.org/10.3389/fonc.2022.871792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339611/
https://www.ncbi.nlm.nih.gov/pubmed/35924153
http://dx.doi.org/10.3389/fonc.2022.871792

Ejemplares similares